drugset / Trial / NCT01893567

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

NCT01893567

Phase 4 Completed 28 enrolled Galderma R&D
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to investigate the utility of a technological based rating scale for assessing improvement in plaque psoriasis with Clobex spray treatment.

Timeline

Start
2013-07
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 %

Indications